ArticleCancer chemotherapy and pharmacology2024

A sub-pharmacological test dose does not predict individual docetaxel exposure in prostate cancer patients.

Marise R Heerma van Voss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.